Govt approves Drugs & Cosmetics Amendment Bill

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 9:47 PM IST

The amendment bill, pending in Rajya Sabha, proposes to increase the quantum of punishment to a person involved in the crimes related to manufacture and sale of spurious drugs.     

"This will help contain the problem of manufacture and trade of spurious drugs," Finance Minister P Chidambaram told reporters after the Cabinet meeting.     

The Bill proposes imprisonment for a term for not less than 10 years which may be extended to life term and fine of not less than Rs 10 lakhs or three times value of the drugs confiscated, whichever is more, for a person involved in manufacture and sale of spurious drugs.     

The central government had constituted an expert committee under the chairmanship of R A Mashelkar, Director General CSIR in 2003 to undertake a comprehensive examination of the problem of spurious drugs.     

The committee recommended for the enhancement of penalties, setting up of special courts for speedy trials and making the offences relating to spurious drugs non-bailable.     

Based on these recommendations, a bill was introduced in Lok Sabha on December 2003 and the bill lapsed due to the dissolution of Lok Sabha.     

It was again introduced in Rajya Sabha in 2005 and would help contain the problem of manufacture and trade of spurious drugs.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 17 2008 | 3:58 PM IST

Next Story